Yale University: all 1,763 studies
Page 18 of 18. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- Effect of Progesterone on Smoking Behavior in Male and Female SmokersCompletedNCT00271206Phase 1
- Glycine Treatment of Prodromal SymptomsCompletedNCT00268749Phase 2
- Enhancing Emergency Practitioner (EP)-Performed Alcohol Interventions in the Emergency Department (ED)CompletedNCT00261859Phase 2/3
- Family-Centered Behavioral Preparation for SurgeryCompletedNCT00261261Not applicable
- Dialysate Sodium Individualization in HemodialysisTerminatedNCT00259714Phase 1
- Microvascular Reactivity.CompletedNCT00259701
- High-dose Periop Statins for Prevention of DVTCompletedNCT00259662Not applicable
- Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human InfantsCompletedNCT00252681Not applicable
- Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic AttackCompletedNCT00251290Phase 2
- Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled TrialCompletedNCT00250900Not applicable
- Aripiprazole Treatment of Prodromal PatientsCompletedNCT00237874Phase 2/3
- Effectiveness of Atypical Versus Conventional Antipsychotics in Treating SchizophreniaCompletedNCT00237861Phase 4
- D-Serine for Enhancing Cognitive Retraining for the Treatment of SchizophreniaCompletedNCT00237848Phase 3
- Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use DisordersCompletedNCT00237822Phase 2
- Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic HypotensionTerminatedNCT00237783Phase 1
- Culturally Responsive Person-Centered Care for PsychosisCompletedNCT00231933Phase 1
- Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional AntipsychoticsCompletedNCT00224276
- Ultrasound Study of the Uterine Healing Process After Cesarean DeliveryCompletedNCT00224250Not applicable
- The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3TerminatedNCT00142883Not applicable
- Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone CaproateWithdrawnNCT00120640Not applicable
- Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00104975Phase 1
- Framing Messages for Smoking Cessation With Bupropion - 6CompletedNCT00104598Not applicable
- RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental DisordersCompletedNCT00080145Not applicable
- Motivational Enhancement for Spanish Speaking Individuals - 1CompletedNCT00078169Phase 3
- Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric DisorderCompletedNCT00048854Phase 1/2
- Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory HallucinationsCompletedNCT00042159Not applicable
- Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1CompletedNCT00032994Phase 3
- Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1CompletedNCT00032981Phase 3
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 2
- Isocyanate Antigens and T Cells That Cause AsthmaCompletedNCT00005549
- Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00004924Phase 2
- Docetaxel and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00004923Phase 1/2
- Acamprosate Treatment: Mechanisms of ActionCompletedNCT00004552Phase 2
- Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00003111Phase 2
- Topotecan Plus Sargramostim in Treating Patients With Advanced CancerCompletedNCT00002950Phase 1/2
- High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerTerminatedNCT00002948Phase 1
- Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1
- Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast CancerCompletedNCT00002680Phase 2
- Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast CancerCompletedNCT00002679Phase 2
- Aminocamptothecin in Treating Patients With T-cell LymphomaCompletedNCT00002635Phase 2
- Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002507Phase 3
- Smoking Cessation in Alcoholism TreatmentCompletedNCT00000454Phase 4
- Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)CompletedNCT00000451Phase 2
- Naltrexone Treatment for Alcoholic WomenCompletedNCT00000448Phase 4
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2CompletedNCT00000319Phase 2
- Combining Behavioral Treatment With Agonist Maintenance - 1CompletedNCT00000311Phase 3
- Pemoline for Cocaine Abuse - 7CompletedNCT00000282Phase 2
- Pharmacotherapy for Schizophrenic Drug Users - 6CompletedNCT00000281Phase 2
- Glutaminergic Agents for Cocaine Abuse - 5CompletedNCT00000280Phase 1
- Novel Medications for Opiate Detoxification - 4CompletedNCT00000279Phase 2
- Disulfiram for Cocaine-Alcohol Abuse - 3CompletedNCT00000278Phase 2
- Mazindol for Cocaine Abuse - 2CompletedNCT00000277Phase 2
- Dopamine Reuptake Inhibitors of Cocaine Abuse - 1TerminatedNCT00000276Phase 1
- Rapid Benzodiazepine Detoxification Using Flumazenil - 1CompletedNCT00000246Phase 2
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1CompletedNCT00000216Phase 3
- Buprenorphine Maintenance for Opioid Addicts - 3CompletedNCT00000204Phase 2
- Buprenorphine Maintenance for Opioid Addicts - 2CompletedNCT00000203Phase 2
- Buprenorphine Maintenance for Opioid Addicts - 1CompletedNCT00000202Phase 2
- Neurobiology of Opioid Dependence: 5 - 5WithdrawnNCT00000196Phase 2
- Neurobiology of Opioid Dependence: 4 - 4WithdrawnNCT00000195Phase 2
- Neurobiology of Opioid Dependence: 3 - 3WithdrawnNCT00000194Phase 2
- Neurobiology of Opioid Dependence: 2 - 2WithdrawnNCT00000193Phase 2
- Neurobiology of Opioid Dependence: 1 - 1WithdrawnNCT00000192Phase 2